159 related articles for article (PubMed ID: 14693749)
21. Prediagnostic circulating follicle stimulating hormone concentrations and ovarian cancer risk.
McSorley MA; Alberg AJ; Allen DS; Allen NE; Brinton LA; Dorgan JF; Kaaks R; Rinaldi S; Helzlsouer KJ
Int J Cancer; 2009 Aug; 125(3):674-9. PubMed ID: 19444906
[TBL] [Abstract][Full Text] [Related]
22. Carbohydrates and the risk of breast cancer among Mexican women.
Romieu I; Lazcano-Ponce E; Sanchez-Zamorano LM; Willett W; Hernandez-Avila M
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1283-9. PubMed ID: 15298947
[TBL] [Abstract][Full Text] [Related]
23. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
24. Recreational physical activity and sedentary behavior in relation to ovarian cancer risk in a large cohort of US women.
Patel AV; Rodriguez C; Pavluck AL; Thun MJ; Calle EE
Am J Epidemiol; 2006 Apr; 163(8):709-16. PubMed ID: 16495470
[TBL] [Abstract][Full Text] [Related]
25. Plasma androgen concentrations and risk of incident ovarian cancer.
Tworoger SS; Lee IM; Buring JE; Hankinson SE
Am J Epidemiol; 2008 Jan; 167(2):211-8. PubMed ID: 17982156
[TBL] [Abstract][Full Text] [Related]
26. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.
Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B
Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823
[TBL] [Abstract][Full Text] [Related]
27. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
[TBL] [Abstract][Full Text] [Related]
28. Serum fructosamine and subsequent breast cancer risk: a nested case-control study in the ORDET prospective cohort study.
Platek M; Krogh V; Micheli A; Browne R; Meneghini E; Sieri S; Schünemann HJ; Pala V; Barba M; Wilding GE; Berrino F; Muti P
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):271-4. PubMed ID: 15668507
[TBL] [Abstract][Full Text] [Related]
29. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.
Serin IS; Tanriverdi F; Yilmaz MO; Ozcelik B; Unluhizarci K
Gynecol Endocrinol; 2008 Mar; 24(3):117-21. PubMed ID: 18335323
[TBL] [Abstract][Full Text] [Related]
30. Free estradiol and breast cancer risk in postmenopausal women: comparison of measured and calculated values.
Endogenous Hormones and Breast Cancer Collaborative Group
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1457-61. PubMed ID: 14693737
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts.
Tworoger SS; Lee IM; Buring JE; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1691-5. PubMed ID: 17684148
[TBL] [Abstract][Full Text] [Related]
32. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.
Barad DH; Weghofer A; Gleicher N
Obstet Gynecol; 2007 Jun; 109(6):1404-10. PubMed ID: 17540814
[TBL] [Abstract][Full Text] [Related]
33. A prospective study of the transient decrease in ovarian cancer risk following childbirth.
Liu Q; Lambe M; Baik I; Cnattingius S; Riman T; Ekbom A; Adami HO; Hsieh CC
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2508-13. PubMed ID: 17164377
[TBL] [Abstract][Full Text] [Related]
34. A case-control study of analgesic use and ovarian cancer.
Rosenberg L; Palmer JR; Rao RS; Coogan PF; Strom BL; Zauber AG; Stolley PD; Shapiro S
Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):933-7. PubMed ID: 11008911
[TBL] [Abstract][Full Text] [Related]
35. Ovarian cancer: can we make the clinical diagnosis earlier?
Smith LH; Morris CR; Yasmeen S; Parikh-Patel A; Cress RD; Romano PS
Cancer; 2005 Oct; 104(7):1398-407. PubMed ID: 16116591
[TBL] [Abstract][Full Text] [Related]
36. Nested case-control study of the association of circulating levels of serum insulin-like growth factor I and insulin-like growth factor binding protein 3 with breast cancer in young women in Norway.
Vatten LJ; Holly JM; Gunnell D; Tretli S
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2097-100. PubMed ID: 18708402
[TBL] [Abstract][Full Text] [Related]
37. Circulating soluble Fas levels and risk of ovarian cancer.
Akhmedkhanov A; Lundin E; Guller S; Lukanova A; Micheli A; Ma Y; Afanasyeva Y; Zeleniuch-Jacquotte A; Krogh V; Lenner P; Muti P; Rinaldi S; Kaaks R; Berrino F; Hallmans G; Toniolo P
BMC Cancer; 2003 Dec; 3():33. PubMed ID: 14690548
[TBL] [Abstract][Full Text] [Related]
38. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
Kaaks R; Rinaldi S; Key TJ; Berrino F; Peeters PH; Biessy C; Dossus L; Lukanova A; Bingham S; Khaw KT; Allen NE; Bueno-de-Mesquita HB; van Gils CH; Grobbee D; Boeing H; Lahmann PH; Nagel G; Chang-Claude J; Clavel-Chapelon F; Fournier A; Thiébaut A; González CA; Quirós JR; Tormo MJ; Ardanaz E; Amiano P; Krogh V; Palli D; Panico S; Tumino R; Vineis P; Trichopoulou A; Kalapothaki V; Trichopoulos D; Ferrari P; Norat T; Saracci R; Riboli E
Endocr Relat Cancer; 2005 Dec; 12(4):1071-82. PubMed ID: 16322344
[TBL] [Abstract][Full Text] [Related]
39. Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina.
Bradbury BD; Lash TL; Kaye JA; Jick SS
Cancer; 2005 Mar; 103(6):1114-21. PubMed ID: 15712362
[TBL] [Abstract][Full Text] [Related]
40. Short-term oral contraceptive use and the risk of epithelial ovarian cancer.
Greer JB; Modugno F; Allen GO; Ness RB
Am J Epidemiol; 2005 Jul; 162(1):66-72. PubMed ID: 15961588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
